Long-term Safety and Performance of CMF Porous Titanium Implants
ConditionCraniofacial Defects
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMaterialise
About this trial
The goal of this retrospective study is to evaluate the clinical characteristics, efficiency, safety, and long-term performance of craniomaxillofacial (CMF) Porous Titanium Implants within the standard of care across children (0 - \<12 years old), adolescent (12 - \<22 years old), and adult (≥ 22 years old) populations.
Eligibility criteria
Qualifiers
Age: Patients of any age are eligible for this study.
Patients treated with Materialise patient-specific CMF Porous Titanium Implants for facial and/or cranial reconstruction.
Patients who have followed Standard of Care, as determined in each case by the treating surgeon.
Disqualifiers
Known hypersensitivity to Titanium at the time of surgery.
Patients who had or will receive the TMJ Total Arthroplasty System.
Pregnancy at the time of surgery.
Trial design
Treatments tested in this trial
- Craniomaxillofacial (CMF) porous titanium implant
Treatment groups
No treatment groups listed
Locations
2Denmark
Rigshospitalet Copenhagen Denmark
France
Hôpital Pitié-Salpêtrière Paris France
Sponsors and collaborators
Materialise
Lead sponsor
Source ClinicalTrials.gov